Quick Answer
Roivant Sciences Ltd. reported Operating Income of -$1.00 billion for fiscal year 2025.
Roivant Sciences Ltd. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$1.00B | -122.3% |
| 2024 | $4.50B | +595.9% |
| 2023 | -$906.76M | +32.9% |
| 2022 | -$1.35B | -26.2% |
| 2021 | -$1.07B | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$339.15M | -23.6% | -10.7% |
| September 30, 2025 | -$306.23M | +10.4% | -7.5% |
| June 30, 2025 | -$284.92M | -178.7% | -3.8% |
| December 31, 2024 | -$274.38M | -105.4% | +19.7% |
| September 30, 2024 | -$341.71M | -59.8% | -234.2% |
| June 30, 2024 | -$102.23M | +63.0% | -102.0% |
| December 31, 2023 | $5.13B | +1456.2% | +2497.2% |
| September 30, 2023 | -$213.89M | +23.8% | +22.6% |
- Roivant Sciences Ltd. showed a decrease of -122.3% in Operating Income compared to the prior fiscal year.
- Over the 2021–2025 period, Roivant Sciences Ltd.’s operating income has grown by 6.3% (from -$1.07 billion to -$1.00 billion).
- The most recent figure is from Roivant Sciences Ltd.’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: